Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference Evaluation of Clarinex vs Zyrtec in Allergic Rhinitis
NCT00794599Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2002
- Primary completion
- Aug 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of desloratadine in seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) (2 arms), sponsored by Organon & Co. Primary endpoint: Preference rates calculated from subject comparative evaluation. Started Dec 2002; status: completed.
02
Drugs
desloratadine
03
Conditions
seasonal allergic rhinitis (SAR)perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00794599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794599.